Search results
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 16 hours agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also ...
List of Eligible Groups for COVID-19 Vaccine Expands March 15 & 29
New Jersey Business Magazine· 2 weeks agoGov. Phil Murphy today announced that the ranks of eligible groups who can receive COVID-19 vaccines...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 1 week agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 1 week agoOrganically, excluding the impact of acquisitions/divestitures and currency, sales rose 4% on an...
Will Biopharma Companies Shun Vaccine R&D In A New Pandemic?
Forbes· 2 weeks agoIn the spring of 2020, Covid-19 essentially shut down the U.S. as well as most of the rest of the...
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
Zacks via Yahoo Finance· 2 weeks agoJ&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex...
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Zacks via Yahoo Finance· 2 weeks agoThis week, J&J JNJ proposed to buy medical device company Shockwave Medical SWAV for approximately...
Cidara regains rights to flu med after Janssen makes good on promise to divest
FierceBiotech· 3 hours agoIn September 2023, Cidara said Janssen had elected to proceed with CD388, triggering a $7 million...
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
CNBC· 1 week agoAn entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28,...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 5 days agoImportant Stories J&J Begins Q1 Earnings Season: J&J’s first-quarter results were mixed as it beat...